scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039388239 |
P356 | DOI | 10.1186/1471-2407-13-192 |
P932 | PMC publication ID | 3637393 |
P698 | PubMed publication ID | 23587173 |
P5875 | ResearchGate publication ID | 236183805 |
P2093 | author name string | Chao Zeng | |
Junli Guo | |||
Shaojiang Zheng | |||
Wei Jie | |||
Zhihua Shen | |||
Qiyi He | |||
Xiaofan Jiang | |||
Ranran Ding | |||
Hanguo Jiang | |||
Yumei Zeng | |||
Botao Luo | |||
P2860 | cites work | Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase | Q24317284 |
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China | Q24647880 | ||
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas | Q24651210 | ||
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma | Q24681972 | ||
Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results | Q25255613 | ||
Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence | Q27007474 | ||
Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10 | Q27638680 | ||
The ubiquitin system | Q27860803 | ||
Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation | Q28728022 | ||
Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches | Q29036707 | ||
Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression | Q33278046 | ||
Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer | Q33420103 | ||
The prevalence and prevention of nasopharyngeal carcinoma in China. | Q33579447 | ||
Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation | Q33616502 | ||
Identification and validation of genes involved in cervical tumourigenesis | Q33825832 | ||
Compromised spindle assembly checkpoint due to altered expression of Ubch10 and Cdc20 in human papillomavirus type 16 E6- and E7-expressing keratinocytes | Q34190709 | ||
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. | Q34215936 | ||
Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin | Q34328127 | ||
A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels | Q34345591 | ||
High resolution allelotype of microdissected primary nasopharyngeal carcinoma. | Q34509844 | ||
Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH. | Q34537773 | ||
Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma | Q34839612 | ||
Nasopharyngeal carcinoma: molecular biomarker discovery and progress | Q35597559 | ||
Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy | Q35956214 | ||
Modeling a lethal prostate cancer variant with small-cell carcinoma features | Q37582049 | ||
Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker. | Q37968528 | ||
Inhibition of Pim-1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells | Q39307228 | ||
Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation | Q39331942 | ||
CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability | Q39540207 | ||
Association of clinicopathological features with UbcH10 expression in colorectal cancer | Q39795425 | ||
Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro | Q39816213 | ||
UbcH10 expression in human lymphomas. | Q39852192 | ||
UbcH10 is overexpressed in malignant breast carcinomas | Q40068570 | ||
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas | Q42599796 | ||
Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors | Q45733871 | ||
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma | Q48323719 | ||
Molecular characterization of central neurocytomas: potential markers for tumor typing and progression | Q48433807 | ||
Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors | Q49026214 | ||
RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo. | Q53320116 | ||
Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma. | Q54633692 | ||
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study | Q82365327 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 192 | |
P577 | publication date | 2013-04-15 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression | |
P478 | volume | 13 |
Q46411728 | Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma |
Q89901919 | Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics |
Q64246447 | Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation |
Q92619115 | Expression of FANCD2 is associated with prognosis in patients with nasopharyngeal carcinoma |
Q37642739 | High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition |
Q38721719 | High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma |
Q47156106 | High glucose promotes vascular smooth muscle cell proliferation by upregulating proto-oncogene serine/threonine-protein kinase Pim-1 expression |
Q91739114 | Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis |
Q38429281 | Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach. |
Q37205779 | Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression |
Q47703632 | Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma. |
Q37363343 | Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression |
Q42363904 | The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data |
Q64238495 | The clinicopathological significance of ubiquitin-conjugating enzyme E2C, leucine-rich repeated-containing G protein-coupled receptor, WW domain-containing oxidoreductase, and vasculogenic mimicry in invasive breast carcinoma |
Q58803439 | UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability |
Q52338003 | UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1. |
Q89622570 | UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer |
Q37629009 | UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria |
Q37662326 | UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines. |
Q64935679 | UBE2C overexpression in melanoma and its essential role in G2/M transition. |
Q64083909 | UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC |
Q38846078 | UBE2S is associated with malignant characteristics of breast cancer cells |
Q31157579 | Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions |
Q36042663 | Vitamin D3 May Ameliorate the Ketoconazole Induced Adrenal Injury: Histological and Immunohistochemical Studies on Albino Rats |
Search more.